CD4 and uveitis: IL-27p28 transgenic mice immunized with IRBP did not develop significant uveitis, showing low disease scores, few percentages of CD4+IL-17A+ and CD4+IFNγ+ T cells in the eyes, and reduced CD4+GM-CSF+ T cells in the ocular cell infiltrate.